A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1
NCT02572388
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Interventions
BIOLOGICAL:
R21
BIOLOGICAL:
Matrix-M1
Sponsor
University of Oxford